PRESS RELEASE published on 04/24/2025 at 17:45, 1 year ago Affluent Medical : RESULTATS ANNUELS 2024 : Affluent Medical franchit de nouveaux jalons clés dans l’exécution de sa feuille de route clinique Affluent Medical franchit de nouveaux jalons clés dans l’exécution de sa feuille de route clinique en 2024, avec des accords stratégiques et des avancées réglementaires majeures Résultats Annuels Affluent Medical Accords Stratégiques Technologies Médicales Feuille De Route Clinique
PRESS RELEASE published on 04/24/2025 at 17:45, 1 year ago Affluent Medical : 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical reached major new milestones in executing its clinical roadmap in 2024, including transformative agreements and positive FDA feedback. Financial results show progress and strategic appointments Financial Results Affluent Medical FDA Feedback Milestones 2024 Full Year Results
PRESS RELEASE published on 04/24/2025 at 17:45, 1 year ago 2024 FULL YEAR RESULTS Affluent Medical reached major new milestones in executing its clinical roadmap Affluent Medical announces major milestones in its 2024 full-year results including transformative agreements, regulatory validations, and clinical advancements, positioning the company for market launch Medical Technology Affluent Medical Clinical Advancements Market Launch 2024 Full-year Results
BRIEF published on 04/15/2025 at 17:50, 1 year ago Des avancées médicales prometteuses vers l'étude SPHINX pour le traitement de l'incontinence urinaire à l'effort (IUE) chez la femme Médical Aisé Appareil Artus Étude SPHINX Incontinence D'effort Féminine Minimalement Invasif
BRIEF published on 04/15/2025 at 17:50, 1 year ago Affluent Medical Advances Towards SPHINX Study for Female SUI Treatment Affluent Medical Artus Device SPHINX Study Female Stress Incontinence Minimally Invasive
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women. Affluent Medical progresses towards European clinical study of Artificial Sphincter Artus for treating Urinary Stress Incontinence in Women. The upcoming SPHINX study will assess device safety and performance Affluent Medical Women European Clinical Study Artificial Sphincter Artus Urinary Stress Incontinence
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year ago Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme. Affluent Medical progresse vers une étude clinique européenne sur le sphincter artificiel Artus pour le traitement de l'incontinence urinaire d'effort chez la femme Affluent Medical Étude Clinique Sphincter Artificiel Artus Incontinence Urinaire D'effort Femme
PRESS RELEASE published on 04/15/2025 at 17:45, 1 year ago Affluent Medical Announces Progress Toward European Clinical Study of Artificial Sphincter Artus for the Treatment of Urinary Stress Incontinence in Women Affluent Medical progresses towards European clinical study of Artus artificial sphincter for treating urinary stress incontinence in women. Minimally invasive procedure feasibility confirmed Affluent Medical Women Artus European Clinical Study Urinary Stress Incontinence
BRIEF published on 04/11/2025 at 17:45, 1 year ago Mise à jour du capital et des droits de vote d'Affluent Medical Euronext Paris Droits De Vote Capital Social AMF Affluent Medical
BRIEF published on 04/11/2025 at 17:45, 1 year ago Update of Affluent Medical's capital and voting rights Euronext Paris Share Capital Voting Rights AMF Affluent Medical
Published on 05/09/2026 at 01:30, 2 days 4 hours ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 2 days 6 hours ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/10/2026 at 16:05, 14 hours 1 minute ago RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
Published on 05/10/2026 at 14:00, 16 hours 6 minutes ago MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 18 hours 21 minutes ago Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 1 day 11 hours ago LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 2 days 9 hours ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/07/2026 at 19:15, 3 days 10 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 10 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 3 days 11 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 3 days 11 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 3 days 11 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL